Rilpivirine as an anti-inflammatory agent in non-alcoholic fatty liver disease: evidence from human hepatocytes, hepatic stellate cells and blood cells

被引：0
|
作者：
Fuster-Martinez, Isabel [1 ,2 ]
Moragrega, Angela B. [1 ,2 ]
Gruevska, Aleksandra [1 ,2 ]
Benedicto, Ana [1 ,2 ]
Tosca, Joan [3 ]
Monton, Cristina [3 ]
Munoz, Elena [4 ]
Dorcaratto, Dimitri [4 ]
Esplugues, Juan V. [1 ,2 ,5 ]
Apostolova, Nadezda [1 ,2 ,5 ]
Blas-Garcia, Ana [2 ,5 ,6 ]
机构：
[1] Univ Valencia, Dept Pharmacol, Valencia, Spain
[2] Univ Hosp Dr Peset, FISABIO, Valencia, Spain
[3] Hosp Clin Univ Valencia, Dept Digest Med, Valencia, Spain
[4] Hosp Clin Univ Valencia, Dept Surg, Liver Biliary & Pancreat Unit, Biomed Res Inst INCLIVA, Valencia, Spain
[5] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Valencia, Spain
[6] Univ Valencia, Dept Physiol, Valencia, Spain
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
WED-505
引用
收藏
页码：S781 / S782
页数：2
相关论文
共 50 条
  • [21] Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
    Zengsheng Lu
    Beihui He
    Zhiyun Chen
    Maoxiang Yan
    Liyan Wu
    BMC Immunology, 21
  • [22] Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease
    Sarmadi, Negar
    Poustchi, Hossein
    Yari, Fatemeh Ali
    Radmard, Amir Reza
    Karami, Sara
    Pakdel, Abbas
    Shabani, Parisa
    Khaleghian, Ali
    PLOS ONE, 2022, 17 (04):
  • [23] Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
    Shen, Hao
    Yu, Han
    Li, Qian-yu
    Wei, Ya-ting
    Fu, Jing
    Dong, Hui
    Cao, Dan
    Guo, Lin-na
    Chen, Lei
    Yang, Yuan
    Xu, Ying
    Wu, Meng-chao
    Wang, Hong-yang
    Chen, Yao
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (11) : 2917 - 2928
  • [24] Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis
    Wu, Xiaoyan
    Shen, Yuzhou
    Chen, Jinsi
    Zhang, Yongchen
    Zeng, Sheng
    Xu, Huihui
    LIFE SCIENCES, 2024, 341
  • [25] Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
    Hao Shen
    Han Yu
    Qian-yu Li
    Ya-ting Wei
    Jing Fu
    Hui Dong
    Dan Cao
    Lin-na Guo
    Lei Chen
    Yuan Yang
    Ying Xu
    Meng-chao Wu
    Hong-yang Wang
    Yao Chen
    Acta Pharmacologica Sinica, 2022, 43 : 2917 - 2928
  • [26] CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
    Chu, Xin
    Jin, Qunyan
    Chen, Hui
    Wood, G. Craig
    Petrick, Anthony
    Strodel, William
    Gabrielsen, Jon
    Benotti, Peter
    Mirshahi, Tooraj
    Carey, David J.
    Still, Christopher D.
    DiStefano, Johanna K.
    Gerhard, Glenn S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [27] CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading
    Xin Chu
    Qunyan Jin
    Hui Chen
    G. Craig Wood
    Anthony Petrick
    William Strodel
    Jon Gabrielsen
    Peter Benotti
    Tooraj Mirshahi
    David J. Carey
    Christopher D. Still
    Johanna K. DiStefano
    Glenn S. Gerhard
    Journal of Translational Medicine, 16
  • [28] Modelling non-alcoholic fatty liver disease using human induced pluripotent stem cells
    Morell, C. M.
    Tilson, S.
    Perrin, M.
    Gieseck, T.
    Geti, I.
    Rimland, C.
    Sampaziotis, F.
    Vallier, L.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S29 - S30
  • [29] Anti-Inflammatory Dietary Approach to Prevent the Development and Progression of Non-Alcoholic Fatty Liver Diseases
    Portius, Dorothea
    LIVERS, 2022, 2 (01): : 78 - 84
  • [30] Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
    Doecke, S.
    Lock, J. F.
    Birkenfeld, A. L.
    Hoppe, S.
    Lieske, S.
    Rieger, A.
    Raschzok, N.
    Sauer, I. M.
    Florian, S.
    Osterhoff, M. A.
    Heller, R.
    Herrmann, K.
    Lindenmueller, S.
    Horn, P.
    Bauer, M.
    Weickert, M. O.
    Neuhaus, P.
    Stockmann, M.
    Moehlig, M.
    Pfeiffer, A. F. H.
    von Loeffelholz, C.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (05) : 547 - 557
12345